Nanoparticle-enabled gene delivery for pediatric brain tumors

Pediatric brain tumors are the leading cause of disease-related death in children, yet effective treatment remains a major clinical challenge. These aggressive tumors have limited therapeutic options capable of crossing the blood-brain barrier (BBB) and frequently recur due to genetic or epigenetic alterations and treatment resistance. Gene therapy offers a promising strategy to address these limitations by modifying gene expression, correcting mutations, or introducing functional genes. Nanoparticle (NP) delivery systems facilitate this approach by protecting genetic cargo and enabling BBB penetration and tumor-specific uptake. This review summarizes current genetic engineering strategies and NP-based delivery systems for pediatric brain tumors, including their design principles and delivery mechanisms, highlights key therapeutic approaches under preclinical and clinical investigations, and discusses the major challenges and future directions in NP-mediated gene therapy for pediatric neuro-oncology. By critically evaluating these developments, we aim to underscore the transformative potential of NP-mediated gene therapies in reshaping treatment paradigms and improving outcomes and quality of life for children.

Authors

Institutions

Publication Details

Journal
Science Advances
Published
2026-11-18
DOI
https://doi.org/10.1126/sciadv.aeh9812
Primary Topic
RNA Interference and Gene Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Nanoparticle-enabled gene delivery for pediatric brain tumors

Thomas Paul Davis, Sui Wang, Xueguang Lu, Maria Kavallaris et al.
Science Advances
RNA Interference and Gene Delivery
article

Nanoparticle-enabled gene delivery for pediatric brain tumors

Thomas Paul Davis, Sui Wang, Xueguang Lu, Maria Kavallaris, Yu Qin, Helen Forgham, David Simon Ziegler, Ruirui Qiao, Jiayuan Zhu, Xiaodi Li
article en

Abstract

Pediatric brain tumors are the leading cause of disease-related death in children, yet effective treatment remains a major clinical challenge. These aggressive tumors have limited therapeutic options capable of crossing the blood-brain barrier (BBB) and frequently recur due to genetic or epigenetic alterations and treatment resistance. Gene therapy offers a promising strategy to address these limitations by modifying gene expression, correcting mutations, or introducing functional genes. Nanoparticle (NP) delivery systems facilitate this approach by protecting genetic cargo and enabling BBB penetration and tumor-specific uptake. This review summarizes current genetic engineering strategies and NP-based delivery systems for pediatric brain tumors, including their design principles and delivery mechanisms, highlights key therapeutic approaches under preclinical and clinical investigations, and discusses the major challenges and future directions in NP-mediated gene therapy for pediatric neuro-oncology. By critically evaluating these developments, we aim to underscore the transformative potential of NP-mediated gene therapies in reshaping treatment paradigms and improving outcomes and quality of life for children.

Science AdvancesVol. 12(47)
The University of Queensland (AU), Chinese Academy of Sciences (CN), UNSW Sydney (AU), Children's Cancer Institute Australia (AU), Beijing National Laboratory for Molecular Sciences (CN), Sydney Children's Hospital (AU), Stanford Medicine (US), Institute of Chemistry (CN), Imperial College London (GB), Stanford University (US)
RNA Interference and Gene Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon